CYPROHEPTADINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cyproheptadine Hydrochloride, and when can generic versions of Cyproheptadine Hydrochloride launch?
Cyproheptadine Hydrochloride is a drug marketed by Actavis Mid Atlantic, Chartwell Molecular, Elysium, Halsey, Morton Grove, Naska, Patrin, Pharm Assoc, Quagen, Rising, Tris Pharma Inc, Am Therap, Appco, Ascot, Beximco Pharms Usa, Chartwell Rx, Duramed Pharms Barr, Heritage Pharma, Kenton, Kv Pharm, Md Pharm, Mountain, Mylan, Novast Labs, Pioneer Pharms, Pliva, Strides Pharma, Superpharm, Vitarine, Watson Labs, and Zydus Pharms. and is included in thirty-nine NDAs.
The generic ingredient in CYPROHEPTADINE HYDROCHLORIDE is cyproheptadine hydrochloride. There are six drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the cyproheptadine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cyproheptadine Hydrochloride
A generic version of CYPROHEPTADINE HYDROCHLORIDE was approved as cyproheptadine hydrochloride by CHARTWELL RX on May 26th, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CYPROHEPTADINE HYDROCHLORIDE?
- What are the global sales for CYPROHEPTADINE HYDROCHLORIDE?
- What is Average Wholesale Price for CYPROHEPTADINE HYDROCHLORIDE?
Summary for CYPROHEPTADINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 31 |
| NDAs: | 39 |
| Finished Product Suppliers / Packagers: | 23 |
| Raw Ingredient (Bulk) Api Vendors: | 92 |
| Clinical Trials: | 29 |
| Patent Applications: | 1,026 |
| DailyMed Link: | CYPROHEPTADINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for CYPROHEPTADINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Kinnov Therapeutics | Phase 1 |
| Corey Hawes | Phase 2/Phase 3 |
| National Center for Advancing Translational Sciences (NCATS) | Phase 2/Phase 3 |
Medical Subject Heading (MeSH) Categories for CYPROHEPTADINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for CYPROHEPTADINE HYDROCHLORIDE
US Patents and Regulatory Information for CYPROHEPTADINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strides Pharma | CYPROHEPTADINE HYDROCHLORIDE | cyproheptadine hydrochloride | TABLET;ORAL | 087129-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pliva | CYPROHEPTADINE HYDROCHLORIDE | cyproheptadine hydrochloride | TABLET;ORAL | 088205-001 | Jul 26, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Strides Pharma | CYPROHEPTADINE HYDROCHLORIDE | cyproheptadine hydrochloride | TABLET;ORAL | 209172-001 | Apr 11, 2018 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Quagen | CYPROHEPTADINE HYDROCHLORIDE | cyproheptadine hydrochloride | TABLET;ORAL | 212491-001 | Feb 24, 2021 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Actavis Mid Atlantic | CYPROHEPTADINE HYDROCHLORIDE | cyproheptadine hydrochloride | SYRUP;ORAL | 086833-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
